Ampliphi Biosciences Corp Share Price Nyse
Equities
APHB
US03211P2020
Biotechnology & Medical Research
Sales 2024 * | 4.54M 357M | Sales 2025 * | 2.75M 216M | Capitalization | 98.34M 7.73B |
---|---|---|---|---|---|
Net income 2024 * | -72M -5.66B | Net income 2025 * | -67M -5.27B | EV / Sales 2024 * | 21.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 35.8 x |
P/E ratio 2024 * |
-1.43
x | P/E ratio 2025 * |
-2.09
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.72% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 10/07/23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 25/10/20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 11/02/20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 08/05/19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 31/03/21 |
1st Jan change | Capi. | |
---|---|---|
+47.02% | 57.87B | |
+41.28% | 40.25B | |
-6.92% | 39.94B | |
-5.16% | 28.54B | |
+11.38% | 26.4B | |
-20.53% | 19.33B | |
+29.81% | 12.4B | |
-0.86% | 12.23B | |
+24.44% | 12.2B |